The Asia Pacific Connected Injectable Drug Delivery Devices market size is $XX million USD in 2018 with XX CAGR from 2015 to 2018, and it is expected to reach $XX million USD by the end of 2025 with a CAGR of XX% from 2020 to 2025.
The global connected drug delivery devices market size reached USD 864.4 Million in 2023. Looking forward, IMARC Group expects the market to reach USD 6,879.9 Million by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032.
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
Connected drug delivery devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 928.38 million by 2028 and will grow at a CAGR of 16.69% in the above mentioned forecast period.
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Connected Drug Delivery Devices Report by Material, Application, and Geography ? Global Forecast to 2023 is a professional and comprehensive research report on the world?s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).
Connected drug delivery devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 928.38 million by 2028 and will grow at a CAGR of 16.69% in the above mentioned forecast period.
The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030. The market is driven by certain factors, including the increasing global geriatric population, increasing incidence of chronic diseases including autoimmune disorders, and rise in demand for self-injectable systems.
The Advanced Parenteral Drug Delivery Devices Market size is forecasted to reach $18.4 billion by 2027 and is expected to grow at a CAGR of 8.6% during the forecast period 2022-2027.
The global advanced dermatology drug delivery devices market size is expected to grow from USD 3,569.8 million in 2021 to USD 8,783.0 million by 2030, at a CAGR of 10.5% from 2022 to 2030. The global advanced dermatology drug delivery devices market is driven by factors such as the global efforts in increasing the adoption of connected devices, increasing number of business synergies with pharmaceutical companies, novel technologies in drug delivery, and the growing focus on prescription/medication adherence. Manufacturers are more focused on producing devices that offer enhanced patient experience through real-time monitoring and data sharing.
Nasal drug has been extensively used and due to its efficacy its popularity is rising. Research and development has helped in making it more effective with less and less harm. This report talks about different market aspect of Nasal Drug Delivery Technology. Market drivers that can affect its growth and Delvens' analyst view on this market.
The global on body drug delivery systems market is expected to register a revenue CAGR of 6.0% during the forecast period. Increasing prevalence of chronic diseases and cancer, rising technological advancement in on body drug delivery systems, increasing product launching and investments by leading companies are some of the key factors driving revenue growth of the on body drug delivery systems market. In addition, rising demand for self-administrative injections is contributing significantly to revenue growth of the market.
The global injectable drug delivery market was valued at US$ 30.5 Bn in 2018, and is expected to exhibit a CAGR of around 9% during the forecast period (2019–2029).
The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5%.
Global injectable drugs market is anticipated to reach USD 513.5 billion by 2024 from value USD 272.7 billion in 2016, growing at a CAGR of 8.23% during the forecast period of 2016 to 2024
Injectable suspensions play a vital role in modern healthcare, providing sustained release formulations of medications for various therapeutic purposes. The global market for injectable suspensions demonstrates robust growth, fueled by increasing prevalence of chronic diseases, advancements in drug delivery technologies, and growing demand for long-acting injectable formulations. According to the latest research by Persistence Market Research, the injectable suspensions market is set to witness positive growth of CAGR 8.7% during 2021-2031.
Market segmentation and targeted marketing strategies are essential for effectively reaching diverse customer segments and addressing specific market needs in the Metal-Organic Frameworks (MOFs) industry. Understanding customer preferences, industry trends, and competitive landscapes enables companies to tailor their marketing efforts and maximize market penetration.
Patient-controlled analgesic (PCA) pumps represent a crucial component in pain management, allowing patients to administer their own pain relief medication at their discretion within prescribed limits. This method provides autonomy, minimizes delays in pain relief, and aligns with individualized patient care. According to Persistence Market Research's projections, the global PCA pumps market is anticipated to grow steadily, with an estimated CAGR of 7.1%, increasing from a valuation of US$ 360 Million in 2023 to US$ 712 Million by 2033.
Key factors contributing to the high CAGR are increasing prevalence of diabetes and lack of awareness. Further, aspects such as technological progressions, product launches and collaborations are fueling the market growth of diabetes devices.
Development of Biopharmaceuticals and Biosimilar Drug Delivery Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D KLE University s College of Pharmacy Belgaum-590010
The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5%.
Key factors contributing to the high CAGR are increasing prevalence of diabetes and lack of awareness. Further, aspects such as technological progressions, product launches and collaborations are fueling the market growth of diabetes devices.
The study methodologies used to examine Market for the forecast period, 2020 - 2026 further classifies the industry by type, geography, end-use and end-user to add more precision and bring to light factors responsible for augmenting business development.
Electronic Data Capture (EDC) Market size in 2020 is estimated to be $361 million, growing at a CAGR of 11.9% during the forecast period 2021-2026. The Electronic Data Capture Market system (EDC) is a computerized system designed to collect clinical data in electronic format and is primarily used in human clinical trials.
In Latin America, the prevalence of OSA was 23.5% in 2013. Sleep aid devices are considered as useful tools for the treatment of sleep disorders. According to the latest research by Persistence Market Research (PMR), the global sleep aid devices market is anticipated to account for over US$ 29,200 Mn, in terms of value, by 2026 end. The report on the sleep aid devices market further projects significant growth potential with CAGR at 4.9% through 2026.
Connected drug delivery devices market revenue will grow manifold with the trend for AI and machine learning in emerging and developed economies. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/4422
BioMEMS devices deployed in hospitals and healthcare facilities are primarily focused on medical screening and diagnostic applications, such as devices that measure point-of-care parameters. Wearable devices that facilitate and assure continuous monitoring without hampering a user’s freedom of movement are being bolstered through new opportunities offered by innovative sensors for human biomedical signal acquisition coupled with wireless connectivity and low power solutions. In addition, greater attention is being accorded to diagnostic MEMS sensors that can assist in performing critical functions, such as cholesterol monitoring, pregnancy monitoring, food allergy detection and DNA analyses. Sensor technologies in several cases provide crucial outcomes and form a major element in the process of assisting in decision-making before obtaining formal clinical intervention and care.
The global wearable medical device market, in terms of value, is projected to reach 12.14 Billion by 2021 from USD 5.31 Billion in 2016, at a CAGR of 18.0% during the forecast period.
The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The global injectable drug delivery formulations technologies market was the largest segment in this market. This is due to surge of biologics and development of nanotechnologies.
The report “Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Disposable syringes are drug delivery devices that are used in injecting varying dose of drug into the body. The dosage volume is fixed depending on the mediation, thereby, allowing the exact amount of drug to be injected without the possibility of human errors.
Pharmaceutical Packaging Market research report categorizes the global market by Veterinary Vaccine Packaging (Aquaculture, Porcine, Livestock), Drug Delivery (Topical, Oral, Pulmonary), Raw Material (LDPE, HDPE), Type (Blister Packs, Vials, Plastic Bottles) & by Geography.
Human Insulin Market size is forecast to reach $27.81 billion by 2025, growing at a CAGR of 5.40% during the forecast period 2020-2025. Insulin is a peptide hormone, secreted in the pancreas by beta cells of the islets of Langerhans, and it helps to regulate glucose metabolism. The rising number of diabetic patients and technological advancements in insulin delivery devices are the major factors driving the growth of the market. The rise in disposable income and increasing awareness about diabetes-related disorders is set to further enhance the overall market demand for human insulin during the forecast period 2020-2025.
The equipment for pharmaceutical packaging market has experienced extensive growth in the past few years, mainly due to the various advancements in the pharmaceutical industry related to drug delivery technologies.
Subcutaneous Drug Delivery Devices refer to tools that are made for the delivery of a drug or therapeutic agent via the specific route of administration. Such devices are used as a part of one or more medical treatments. These devices help in increasing the efficiency of drug delivery system by controlling dosage, time, and place of release of the drugs in the body.
The healthcare adhesive tapes market is projected to grow at USD 37.3 billion by 2023, at a CAGR of 6.51%. The major factor driving the healthcare adhesive tapes market includes the increase in demand for surgeries, wound dressings, hygiene, transdermal drug delivery, and many others, owing to their advantages in many medical applications. https://www.marketsandmarkets.com/PressReleases/healthcare-adhesive-tape.asp
The global home healthcare market size is projected to reach USD 298.2 billion by 2026 from USD 198.9 billion in 2021, at a CAGR of 8.4% during the forecast period. Market growth is driven mainly by factors such as rapid growth in the elderly population, the rising incidence of chronic diseases, the growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements in home care devices. The emerging Asian countries are also expected to offer substantial growth opportunities for players in the market.
The global video doorbell market size is expected to reach USD 5.74 Billion by 2028 and register a CAGR of 17.3%, according to the latest report by Emergen Research. Key factors such as rising adoption of Artificial Intelligence (AI), rapid growth in digitalization, and increasing need for deployment of video doorbells are driving global market revenue growth. A video doorbell also called a doorbell camera is an outdoor camera installed on the front door of the house and is connected to smartphones or other electronic devices via internet. Video doorbell notifies the owner about the guest or person present at the doorstep.
Medical services require wires and cables for measurement and treatment purposes. For medical cable assemblies that must withstand a high number of steam autoclave cycles, silicone-jacketed cable and silicone over-molding of strain reliefs are typically required. Medical tubing is one of the major applications of silicone and is used in devices such as respirators and intravenous drug. Apart from these, silicone are also used in ventilation masks, transfusion delivery systems, handles for surgical instruments, breading tubes, microphone holders for hearing aids, tube connector and many other.
Explore innovations in the respiratory market, analyzing growth rate, market size, and key players. Discover advancements in respiratory monitoring devices and protective equipment for comprehensive navigation of this dynamic industry.
Medical services require wires and cables for measurement and treatment purposes. For medical cable assemblies that must withstand a high number of steam autoclave cycles, silicone-jacketed cable and silicone over-molding of strain reliefs are typically required. Medical tubing is one of the major applications of silicone and is used in devices such as respirators and intravenous drug. Apart from these, silicone are also used in ventilation masks, transfusion delivery systems, handles for surgical instruments, breading tubes, microphone holders for hearing aids, tube connector and many other.
Global Wearable Technology Market size is projected to be valued $58 Billion by 2024; with a CAGR of 15.7% from 2017 to 2025. Wearable technology comprises electronic devices that are capable of connecting with interne
Prediction Markets Leighton Vaughan Williams Professor of Economics and Finance Nottingham Business School Nottingham Trent University Leighton.Vaughan-Williams@ntu.ac.uk
Wearable Technology Market (By Applications: Healthcare and Medical, Infotainment, Industrial and Military, And Fitness and Wellness; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015 – 2024
The global medical device contract manufacturing market is anticipated to grow at a double digit CAGR during the forecast period. Medical device contract manufacturing organization provide services to outsource manufacturing of devices that enables original equipment manufacturers (OEMs) to reduce cost of product, product packaging and transport of product.